Search Results 101-110 of 16252 for Hemofilia
Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...
The purpose of this study is to build a Mayo Clinic registry of data and biobank from subjects with drug allergy. The data collected will include demographic, ...
The purpose of this study is to collect blood cells as a healthy donor for use in research studies, which will focus especially on using the immune system's ...
Mayo Clinic researcher Lioudmila V. Karnatovskaia, M.D., strives to improve outcomes for people surviving critical illnesses.
Mayo Clinic researcher Radhika Dhamija, M.B.B.S., is a neurologist and geneticist specializing in rare and undiagnosed diseases.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to evaluate the effectiveness and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatment of ...
About this study. The purposes of this study are to compare the functional connectivity in adolescent patients with Postural Orthostatic Tachycardia ...
About this study. The purpose of this study is to test (in 2 stages) the safety/tolerability, pharmacokinetics (how the body handles study drug) and ...
About this study. Currently, only a few international institutions use CIRT to treat pelvic bone sarcomas. Accordingly, data evaluating the potential ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of healthcare.